|
Amantadine Susceptibility Testing by Sequencing
|
Susceptibility Testing
|
Influenza A virus
|
Influenza, Respiratory Viruses and Coronaviruses
|
|
Antigenic Strain Characterization
|
Strain Characterization
|
SARS-CoV-2
|
Influenza, Respiratory Viruses and Coronaviruses
|
|
Anti-HBc Total (IgG/IgM) Enzyme Immunoassay (EIA)
|
Serology
|
Hepatitis B virus (HBV)
|
Viral Hepatitis and Bloodborne Pathogens Section
|
|
Anti-HBe Enzyme Immunoassay (EIA)
|
Serology
|
Hepatitis B virus (HBV)
|
Viral Hepatitis and Bloodborne Pathogens Section
|
|
Anti-HBs Enzyme Immunoassay (EIA)
|
Serology
|
Hepatitis B virus (HBV)
|
Viral Hepatitis and Bloodborne Pathogens Section
|
|
Anti-HDV Enzyme Immunoassay (EIA)
|
Serology
|
Hepatitis Delta virus (HDV)
|
Viral Hepatitis and Bloodborne Pathogens Section
|
|
Anti-HEV – IgG Enzyme Immunoassay (EIA)
|
Serology
|
Hepatitis E virus (HEV)
|
Viral Hepatitis and Bloodborne Pathogens Section
|
|
Anti-HEV – IgM Enzyme Immunoassay (EIA)
|
Serology
|
Hepatitis E virus (HEV)
|
Viral Hepatitis and Bloodborne Pathogens Section
|
|
Antimicrobial Susceptibility Reference Testing
|
Reference Service
|
Corynebacterium diphtheriae species complex
|
Special Bacteriology Unit
|
|
Antimicrobial Susceptibility Testing
|
Susceptibility Testing
|
Haemophilus influenzae
|
Invasive Bacterial Diseases Section
|
|
Antimicrobial Susceptibility Testing
|
Susceptibility Testing
|
Streptococcus agalactiae
|
Invasive Bacterial Diseases Section
|
|
Antimicrobial Susceptibility Testing
|
Susceptibility Testing
|
Streptococcus pneumoniae
|
Invasive Bacterial Diseases Section
|
|
Antimicrobial Susceptibility Testing
|
Susceptibility Testing
|
Gram-negative organisms
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Antimicrobial Susceptibility Testing
|
Susceptibility Testing
|
Gram-positive organisms
|
Antimicrobial Resistance and Nosocomial Infections
|
|
Antimicrobial Susceptibility Testing
|
Susceptibility Testing
|
Streptococcus pyogenes
|
Invasive Bacterial Diseases Section
|
